epidemic

The African Risk Capacity (ARC), a provider of parametric disaster insurance products, has launched its first epidemic risk transfer product, with the parametric insurance backed by Munich Re as the lead reinsurance company and initially covering Senegal.

Global broker and risk consultancy Marsh has launched PathogenRX, an insurance product designed to protect businesses against pandemic risks such as the outbreak of infectious diseases, that utilises a parametric trigger provided by epidemic risk modeling specialists Metabiota and capacity from reinsurance giant Munich Re.

The African Risk Capacity (ARC), a parametric sovereign disaster risk insurer for African nations, has begun a pilot with the help of San Francisco based Metabiota to roll-out parametric insurance cover against disease outbreaks and epidemics.

The African Risk Capacity (ARC), the provider of parametric sovereign disaster risk insurance and other support to African nations, has launched a new insurance product designed to cover disease outbreaks and epidemics.

San Francisco based Metabiota, a company focused on risk analytics for epidemics, has launched its first commercial risk modelling platform and a preparedness index to help insurance or reinsurance firms and ILS funds or investors understand and underwrite epidemic risk.

Global reinsurance firm Swiss Re has continued its trend of redeeming its series of Vita Capital mortality linked catastrophe bonds, with its $275m 2012 transaction Vita Capital V Ltd. called a year early and investors to be paid a premium of 1%.

San Francisco based Metabiota, a company focused on risk analytics for epidemic, is working with reinsurance and insurance companies to create risk transfer and financing solutions that can provide epidemic or outbreak insurance.

Reinsurer Swiss Re has released some comments on the completion of their latest extreme mortality securitization, Vita Capital V Ltd. As we wrote earlier today, Vita Capital V successfully completed at $275m yesterday and received its ratings. It’s Swiss Re’s fifth Vita securitization in the last three years and the sixth we have recorded in […]

Swiss Re’s sixth issuance in their series of Vita mortality-linked catastrophe bond (or insurance-linked security) deals has completed successfully. Vita Capital V Ltd. completed and received its formal ratings yesterday after being in the market since we first wrote about the deal three weeks ago, during which time it nearly tripled in size to secure […]

As we wrote recently, Swiss Re are marketing the sixth issuance in their series of Vita mortality-linked catastrophe bond (or insurance-linked security) deals. The transaction, Vita Capital V Ltd. , which has been marketing for two weeks began as a $100m deal split into two tranches of mortality-linked notes according to the rating documentation and […]